https://smallmoleculetechnologies.com/wp-content/uploads/2014/12/Small-Molecule-Technologies-Pinnaclife-background.jpg
Sulforaphane
Calkins 2008 “The Nrf2/ARE Pathway as a Potential Therapeutic Target in Neurodegenerative Disease”
Dash 2009 “Sulforaphane Improves Cognitive Function Administered Following Traumatic Brain Injury”
Houghton 2013 “Sulforaphane: translational research from laboratory bench to clinic”
Kensler 2012 “KEAP1-Nrf2 Signaling: A Target for Cancer Prevention by Sulforaphane”
Myzak 2004 “A Novel Mechanism of Chemoprotection by Sulforaphane: Inhibition of Histone Deacetylase”
Myzak 2006 “ Dietary Agents as Histone Deacetylase Inhibitors”
Riedl 2008 “Oral Sulforaphane increases Phase-II antioxidant enzymes in the human upper airway”
Singh 2014 “Sulforaphane treatment of autism spectrum disorder (ASD)”
